Related Experiment Video
Updated: Aug 3, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Cardiovascular implications of inflammatory bowel disease: An updated review
Arshia Bhardwaj1, Arshdeep Singh1, Vandana Midha2
1Department of Gastroenterology, Dayanand Medical College and Hospital, Punjab, Ludhiana 141001, India.
Insights
Patients with inflammatory bowel disease (IBD) face increased risks of atherosclerotic cardiovascular diseases (ASCVD). This review examines IBD-ASCVD links, mechanisms, and treatment impacts on heart health.
Area of Science:
- Gastroenterology
- Cardiology
- Rheumatology
Background:
- Chronic inflammatory disorders, like inflammatory bowel disease (IBD), are increasingly linked to higher risks of atherosclerotic cardiovascular diseases (ASCVD).
- Understanding this association is crucial for managing patient health comprehensively.
Purpose of the Study:
- To review epidemiological data connecting IBD and ASCVD.
- To elucidate potential underlying mechanisms driving this association.
- To evaluate the cardiovascular risks associated with IBD treatments, including novel small molecule drugs.
Main Methods:
- Comprehensive literature search of PubMed (inception to August 2023).
- Keywords included IBD (Crohn's disease, ulcerative colitis) and ASCVD (coronary artery disease, heart failure, atrial fibrillation, etc.).
- Inclusion of diverse study types: cohort studies, clinical trials, meta-analyses, and guidelines.
Main Results:
- Emerging data confirms a heightened ASCVD risk in IBD patients.
- Potential mechanisms linking IBD and ASCVD are explored.
- Cardiovascular effects of IBD therapies, including small molecule drugs, are analyzed, with comparisons to rheumatoid arthritis.
Conclusions:
- There is a significant intersection between inflammatory bowel disease and cardiovascular health.
- Further research and clinical attention are warranted to mitigate ASCVD risk in IBD patients.
- Evaluation of cardiovascular safety profiles for IBD treatments is essential.
Abstract:
Emerging data highlights the heightened risk of atherosclerotic cardiovascular diseases (ASCVD) in patients with chronic inflammatory disorders, particularly those afflicted with inflammatory bowel disease (IBD). This review delves into the epidemiological connections between IBD and ASCVD, elucidating potential underlying mechanisms. Furthermore, it discusses the impact of current IBD treatments on cardiovascular risk. Additionally, the cardiovascular adverse effects of novel small molecule drugs used in moderate-to-severe IBD are investigated, drawing parallels with observations in patients with rheumatoid arthritis. This article aims to comprehensively evaluate the existing evidence supporting these associations. To achieve this, we conducted a meticulous search of PubMed, spanning from inception to August 2023, using a carefully selected set of keywords. The search encompassed topics related to IBD, such as Crohn's disease and ulcerative colitis, as well as ASCVD, including coronary artery disease, cardiovascular disease, atrial fibrillation, heart failure, conduction abnormalities, heart blocks, and premature coronary artery disease. This review encompasses various types of literature, including retrospective and prospective cohort studies, clinical trials, meta-analyses, and relevant guidelines, with the objective of providing a comprehensive overview of this critical intersection of inflammatory bowel disease and cardiovascular health.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations

